我院2008-2010年调血脂药应用分析  

Applied analysis of lipid regulating agents in our hospital from 2008 to 2010

作　　者：谭德涛[1] 田静[1] 李兴德[1] 

机构地区：[1]昆明医学院附属甘美医院(昆明市第一人民医院),昆明市650011

出　　处：《临床合理用药杂志》2012年第5期35-37,共3页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的分析调血脂药的使用情况及用药趋势,促进合理用药。方法对该院2008-2010年调血脂药的购药金额、用药频度(DDDs)、日均用药金额(DDDc)及年均增长率进行统计分析。结果 DDDs居首位的血脂调节药为他汀类,单品种DDDs排序前2位的是阿托伐他汀钙、辛伐他汀。结论他汀类调血脂药是该院临床上主要的调血脂药,总体用药情况较合理。Objective To analyze the utilization and medication tendency of lipid regulating agents for promoting rational administration. Methods The statistical analysis of amount of money, medication frequency, fee expense per day and annum average growth rate of lipid regulating agents were caught out in the hospital from 2008 to 2010. Results The commonest combined drug was Atni-hypertension drugs. DDDs ranking of the previous two were Atorvastatin Calcium, Simvastatin. Conclusion The major lipid regulating agent of our hospital is statins. The use is rational as a whole.

关 键 词：调血脂药 限定日剂量 用药频度 合理用药 

分 类 号：R95[医药卫生—药学]